Drug companies and researchers will no longer be able to withhold the results of unfavorable clinical trials, if changes to European law are passed as expected next month.
via WSJ.com: US Business http://ift.tt/1hRjZbf
via WSJ.com: US Business http://ift.tt/1hRjZbf
Nessun commento:
Posta un commento